Endo Pharma starts sales-rep cuts
Just one month after agreeing to buy Penwest Pharmaceuticals for $144 million, Endo Pharmaceuticals is in the process of laying off sales managers and sales reps, sources tell Pharmalot. Report
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
Latest Commentary
EVENTS
- MDMA Annual Meeting May 30th - June 1st, 2012 — Washington, DC
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- What’s your BIO?June 18-21, 2012 — Boston, MA
Press Releases
- New York Genome Center Announces Formal Commencement of Collaborative Relationship with Illumina
- Baxano Completes Enrollment in Lumbar Spinal Stenosis Study
- PRA Expands Operations in Europe
- New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
- Greatbatch to Establish New Global Headquarters
- More Press Releases
Featured Jobs
-
Sr. Director, Healthcare Compliance Audit Job
Celgene Corporation - Summit, NJ, US -
Oncology Knowledge Lead
Merck - Boston, MA -
District Sales Manager
Vivus, Inc. - -
Neurosciences Knowledge Group Lead
Merck - Rahway, NJ - Kenilworth, NJ - West Point, PA - Boston, MA -
Analytical Scientist Job
Yoh - Durham, NC, USA
Comments